Skip to content

A comparative study of the value of DWIBS and PET/CT in the exploration of systemic metastatic lesions in lung cancer

A comparative study of the value of DWIBS and PET/CT in the exploration of systemic metastatic lesions in lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078991
Enrollment
Unknown
Registered
2023-12-22
Start date
2023-12-22
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Gold Standard:In this study, the location and number of metastases were determined through follow-up. During the six-month follow-up period, one of the following three conditions is met to determine m
Index test:The image obtained by DWIBS scan.

Sponsors

Yunnan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: age >= 18 years, patients with pathologically confirmed diagnosis of lung cancer, no contraindications to MRI examination or PET/CT examination, PET/CT examination data were available

Exclusion criteria

Exclusion criteria: Have other primary tumors, have metal artifacts such as dentures that affect image quality, and cannot perform DWIBS before or within two weeks after PET/CT scanning

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;

Secondary

MeasureTime frame
Consistency of subjective evaluation of image quality results;

Countries

China

Contacts

Public ContactRuimin You

Yunnan Cancer Hospital

youruimin167@163.com+86 182 8845 6300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026